Department of Medicine, University of California San Francisco, San Francisco, California, United States of America.
Infectious Disease and Immunity Graduate Group, University of California Berkeley, California, United States of America.
PLoS Pathog. 2020 Oct 21;16(10):e1008997. doi: 10.1371/journal.ppat.1008997. eCollection 2020 Oct.
Vγ9Vδ2 T cells rapidly respond to phosphoantigens produced by Plasmodium falciparum in an innate-like manner, without prior antigen exposure or processing. Vδ2 T cells have been shown to inhibit parasite replication in vitro and are associated with protection from P. falciparum parasitemia in vivo. Although a marked expansion of Vδ2 T cells is seen after acute malaria infection in naïve individuals, repeated malaria causes Vδ2 T cells to decline both in frequency and in malaria-responsiveness, and to exhibit numerous transcriptional and phenotypic changes, including upregulation of the Fc receptor CD16. Here we investigate the functional role of CD16 on Vδ2 T cells in the immune response to malaria. We show that CD16+ Vδ2 T cells possess more cytolytic potential than their CD16- counterparts, and bear many of the hallmarks of mature NK cells, including KIR expression. Furthermore, we demonstrate that Vδ2 T cells from heavily malaria-exposed individuals are able to respond to opsonized P.falciparum-infected red blood cells through CD16, representing a second, distinct pathway by which Vδ2 T cells may contribute to anti-parasite effector functions. This response was independent of TCR engagement, as demonstrated by blockade of the phosphoantigen presenting molecule Butyrophilin 3A1. Together these results indicate that Vδ2 T cells in heavily malaria-exposed individuals retain the capacity for antimalarial effector function, and demonstrate their activation by opsonized parasite antigen. This represents a new role both for Vδ2 T cells and for opsonizing antibodies in parasite clearance, emphasizing cooperation between the cellular and humoral arms of the immune system.
Vγ9Vδ2 T 细胞可迅速以先天样方式对疟原虫产生的磷酸抗原作出反应,而无需预先接触抗原或加工。已经表明 Vδ2 T 细胞可抑制寄生虫在体外的复制,并与体内对疟原虫寄生虫血症的保护有关。尽管在未感染个体的急性疟疾感染后可以看到 Vδ2 T 细胞的显著扩增,但反复疟疾会导致 Vδ2 T 细胞的频率和对疟疾的反应性下降,并表现出许多转录和表型变化,包括 Fc 受体 CD16 的上调。在这里,我们研究了 CD16 在 Vδ2 T 细胞对疟疾免疫反应中的功能作用。我们表明,CD16+Vδ2 T 细胞比其 CD16-对应物具有更强的细胞毒性潜力,并且具有许多成熟 NK 细胞的特征,包括 KIR 表达。此外,我们证明来自重度疟疾暴露个体的 Vδ2 T 细胞能够通过 CD16 对被调理的感染疟原虫的红细胞作出反应,这代表了 Vδ2 T 细胞可能有助于抗寄生虫效应功能的另一种独特途径。这种反应与 TCR 结合无关,如通过阻断磷酸抗原呈递分子 Butyrophilin 3A1 所证明的。这些结果共同表明,重度疟疾暴露个体中的 Vδ2 T 细胞保留了抗疟效应功能的能力,并证明了它们通过调理的寄生虫抗原被激活。这代表了 Vδ2 T 细胞和调理抗体在寄生虫清除中的新作用,强调了免疫系统的细胞和体液臂之间的合作。